Tranexamic Acid USP For Compounding (API)

Topiramate USP for Compounding (API) is an active pharmaceutical ingredient used to create personalized medications for managing epilepsy and migraine prophylaxis. Known for its anticonvulsant properties, it helps control seizures and reduce the frequency of migraines by stabilizing electrical activity in the brain. In a compounding setting, pharmacists can tailor specific dosages and formulations to meet unique patient needs, especially for those who experience adverse effects with standard treatments or require customized dosage forms for effective management. Ships in 2-4 business days. Tranexamic Acid USP for compounding is a medication used for the treatment or prevention of excessive bleeding or hemorrhage. It is commonly used during surgeries, dental procedures, and for heavy menstrual bleeding. Tranexamic Acid works by preventing the breakdown of blood clots, thereby reducing bleeding. It is also used as an antifibrinolytic agent to treat conditions such as hemophilia and von W